Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Perrigo Company plc before investing.

In this article, we go over a few key elements for understanding Perrigo Company plc’s stock price such as:

• Perrigo Company plc’s current stock price and volume
• Why Perrigo Company plc’s stock price changed recently
• Upgrades and downgrades for PRGO from analysts
• PRGO’s stock price momentum as measured by its relative strength

About Perrigo Company plc (PRGO)

Before we jump into Perrigo Company plc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Want to learn more about Perrigo Company plc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Perrigo Company plc.

Perrigo Company plc’s Stock Price as of Market Close

As of July 29, 2026, 1:31 PM, CST, Perrigo Company plc’s stock price was $10.265.

Perrigo Company plc is down 0.34% from its previous closing price of $10.300.

During the last market session, Perrigo Company plc’s stock traded between $10.170 and $10.530. Currently, there are approximately 138.70 million shares outstanding for Perrigo Company plc.

Perrigo Company plc’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Perrigo Company plc Stock Price History

Perrigo Company plc’s (PRGO) price is currently down 1.2% so far this month.

During the month of July, Perrigo Company plc’s stock price has reached a high of $11.590 and a low of $9.810.

Over the last year, Perrigo Company plc has hit prices as high as $28.220 and as low as $9.225. Year to date, Perrigo Company plc’s stock is down 26.26%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Perrigo Company plc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 28, 2026, there was 1 analyst who downgraded Perrigo Company plc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Perrigo Company plc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Perrigo Company plc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Perrigo Company plc’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Perrigo Company plc (PRGO) by visiting AAII Stock Evaluator.

Relative Price Strength of Perrigo Company plc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 28, 2026, Perrigo Company plc has a weighted four-quarter relative price strength of -22.50%, which translates to a Momentum Score of 11 and is considered to be Very Weak.

Want to learn more about how Perrigo Company plc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Perrigo Company plc Stock Price: Bottom Line

As of July 29, 2026, Perrigo Company plc’s stock price is $10.265, which is down 0.34% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Perrigo Company plc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.